BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 26026108)

  • 21. Efficacy of preoperative radiochemotherapy in patients with locally advanced pancreatic carcinoma.
    Lind PA; Isaksson B; Almström M; Johnsson A; Albiin N; Byström P; Permert J
    Acta Oncol; 2008; 47(3):413-20. PubMed ID: 17882555
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemoradiation therapy sequencing for resected pancreatic adenocarcinoma in the National Cancer Data Base.
    Colbert LE; Hall WA; Nickleach D; Switchenko J; Kooby DA; Liu Y; Gillespie T; Lipscomb J; Kauh J; Landry JC
    Cancer; 2014 Feb; 120(4):499-506. PubMed ID: 24390739
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Significance of histological response to preoperative chemoradiotherapy for pancreatic cancer.
    White RR; Xie HB; Gottfried MR; Czito BG; Hurwitz HI; Morse MA; Blobe GC; Paulson EK; Baillie J; Branch MS; Jowell PS; Clary BM; Pappas TN; Tyler DS
    Ann Surg Oncol; 2005 Mar; 12(3):214-21. PubMed ID: 15827813
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Locally advanced pancreatic cancer: association between prolonged preoperative treatment and lymph-node negativity and overall survival.
    Kadera BE; Sunjaya DB; Isacoff WH; Li L; Hines OJ; Tomlinson JS; Dawson DW; Rochefort MM; Donald GW; Clerkin BM; Reber HA; Donahue TR
    JAMA Surg; 2014 Feb; 149(2):145-53. PubMed ID: 24306217
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of chemoradiotherapy after disease control with chemotherapy in locally advanced pancreatic adenocarcinoma in GERCOR phase II and III studies.
    Huguet F; André T; Hammel P; Artru P; Balosso J; Selle F; Deniaud-Alexandre E; Ruszniewski P; Touboul E; Labianca R; de Gramont A; Louvet C
    J Clin Oncol; 2007 Jan; 25(3):326-31. PubMed ID: 17235048
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adjuvant therapy and survival after resection of pancreatic adenocarcinoma: a population-based analysis.
    Mayo SC; Austin DF; Sheppard BC; Mori M; Shipley DK; Billingsley KG
    Cancer; 2010 Jun; 116(12):2932-40. PubMed ID: 20336787
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pancreatic neuroendocrine tumors with involved surgical margins: prognostic factors and the role of adjuvant radiotherapy.
    Arvold ND; Willett CG; Fernandez-del Castillo C; Ryan DP; Ferrone CR; Clark JW; Blaszkowsky LS; Deshpande V; Niemierko A; Allen JN; Kwak EL; Wadlow RC; Zhu AX; Warshaw AL; Hong TS
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):e337-43. PubMed ID: 22414286
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical experience with chronomodulated infusional 5-fluorouracil chemoradiotherapy for pancreatic adenocarcinoma.
    Keene KS; Rich TA; Penberthy DR; Shepard RC; Adams R; Jones RS
    Int J Radiat Oncol Biol Phys; 2005 May; 62(1):97-103. PubMed ID: 15850908
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adjuvant radiotherapy and lymph node dissection in pancreatic cancer treated with surgery and chemotherapy.
    Mellon EA; Springett GM; Hoffe SE; Hodul P; Malafa MP; Meredith KL; Fulp WJ; Zhao X; Shridhar R
    Cancer; 2014 Apr; 120(8):1171-7. PubMed ID: 24390779
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Outcomes and tolerability of chemoradiation therapy for pancreatic cancer patients aged 75 years or older.
    Miyamoto DT; Mamon HJ; Ryan DP; Willett CG; Ancukiewicz M; Kobayashi WK; Blaszkowsky L; Fernandez-del Castillo C; Hong TS
    Int J Radiat Oncol Biol Phys; 2010 Jul; 77(4):1171-7. PubMed ID: 19800182
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outcomes of adjuvant chemoradiotherapy after a radical gastrectomy and a D2 node dissection for gastric adenocarcinoma.
    Leong CN; Chung HT; Lee KM; Shakespeare TP; Mukherjee RK; Wong LC; Lu JJ; Tey J; Lim R; So JB; Back MF
    Cancer J; 2008; 14(4):269-75. PubMed ID: 18677137
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Resection versus palliation: treatment of stage III and IVA carcinomas of the pancreas employing intraoperative radiation.
    Okamoto A; Tsuruta K; Karasawa K; Miyanari N; Matsumoto G; Kamisawa T; Egawa N
    World J Surg; 2003 May; 27(5):599-605. PubMed ID: 12715231
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patterns of Care and Outcomes of Adjuvant Chemoradiation for Node-Positive Pancreatic Adenocarcinoma.
    Malakhov N; Lee A; Albert A; Lederman A; Byun J; Safdieh J; Schreiber D
    J Gastrointest Cancer; 2020 Jun; 51(2):506-514. PubMed ID: 31236851
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Updated long-term outcomes and prognostic factors for patients with unresectable locally advanced pancreatic cancer treated with intraoperative radiotherapy at the Massachusetts General Hospital, 1978 to 2010.
    Cai S; Hong TS; Goldberg SI; Fernandez-del Castillo C; Thayer SP; Ferrone CR; Ryan DP; Blaszkowsky LS; Kwak EL; Willett CG; Lillemoe KD; Warshaw AL; Wo JY
    Cancer; 2013 Dec; 119(23):4196-204. PubMed ID: 24006012
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of adjuvant radiotherapy on survival after pancreatic cancer resection: an appraisal of data from the national cancer data base.
    Kooby DA; Gillespie TW; Liu Y; Byrd-Sellers J; Landry J; Bian J; Lipscomb J
    Ann Surg Oncol; 2013 Oct; 20(11):3634-42. PubMed ID: 23771249
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adjuvant chemotherapy versus chemoradiation in high-risk pancreatic adenocarcinoma: A propensity score-matched analysis.
    Raoof M; Blakely AM; Melstrom LG; Lee B; Warner SG; Chung V; Singh G; Chen YJ; Fong Y
    Cancer Med; 2019 Oct; 8(13):5881-5890. PubMed ID: 31414566
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adjuvant chemotherapy, with or without postoperative radiotherapy, for resectable advanced pancreatic adenocarcinoma: continue or stop?
    Ren F; Xu YC; Wang HX; Tang L; Ma Y
    Pancreatology; 2012; 12(2):162-9. PubMed ID: 22487527
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adjuvant therapy for margin positive pancreatic cancer: A propensity score matched analysis.
    Takahashi C; Shridhar R; Huston J; Meredith K
    Pancreatology; 2022 Apr; 22(3):396-400. PubMed ID: 35304103
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pancreatic cancer within a UK cancer network with special emphasis on locally advanced non-metastatic pancreatic cancer.
    Mukherjee S; Hudson E; Reza S; Thomas M; Crosby T; Maughan T
    Clin Oncol (R Coll Radiol); 2008 Sep; 20(7):535-40. PubMed ID: 18346883
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Postoperative Radiotherapy for Pancreatic Cancer with Microscopically-positive Resection Margin.
    Park S; Kim SC; Hong SM; Lee YJ; Park KM; Hwang DW; Lee JH; Song KB; Ryoo BY; Jang HM; Kim KP; Yu C; Choi EK; DO Ahn S; Lee SW; Yoon SM; Park JH; Kim JH
    Anticancer Res; 2017 Feb; 37(2):755-764. PubMed ID: 28179327
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.